Company intelligence / Profile preview

BPS Bioscience

San Diego, California, United Statesbpsbioscience.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

BPS Bioscience does not develop its own drugs but provides over 4000 recombinant proteins/cell lines/assays to enable drug discovery in areas such as immunotherapy, epigenetics, DNA repair pathways. Their products have been cited in over 4000 scientific publications since 2010.

Therapeutic areas: OtherInfectious Diseases
Modalities: Recombinant proteinCell line (engineered and iPSC-derived)Lentivirus-based tools (for gene editing and cell engineering)Assay kit (biochemical and cell-based)Small molecule screening servicesCRISPR-based reagents/tools
Industry: Drug Discovery Services

Partnerships

No major pharma partnerships disclosed publicly. Distributes through partners like Cambridge Bioscience in the UK/Ireland

Beyond the preview

Go deeper on BPS Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BPS Bioscience.

Explore the full profile